The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's current EPS (TTM) is HK$109.84. In 2022 the company made an earnings per share (EPS) of HK$94.55 an increase over its 2021 EPS that were of HK$80.42.
Year | EPS | Change |
---|---|---|
2023 (TTM) | HK$110.87 | 17.26% |
2022 | HK$94.55 | 17.57% |
2021 | HK$80.42 | -16.38% |
2020 | HK$96.18 | -4.32% |
2019 | HK$100.53 | 2.05% |
2018 | HK$98.51 | 382.51% |
2017 | HK$20.42 | -74.52% |
2016 | HK$80.11 | 12.66% |
2015 | HK$71.11 | 34.9% |
2014 | HK$52.71 | 0.74% |
2013 | HK$52.32 | 20.36% |
2012 | HK$43.47 | 37.93% |
2011 | HK$31.52 | -15.77% |
2010 | HK$37.42 | 6.4% |
2009 | HK$35.17 | 19.84% |
2008 | HK$29.34 | 35% |
2007 | HK$21.74 | 12% |
2006 | HK$19.41 | -15.54% |
2005 | HK$22.98 | 59.14% |
2004 | HK$14.44 | 6.9% |
2003 | HK$13.51 | -289.13% |
2002 | -HK$7.14 | -186.79% |
2001 | HK$8.23 | -4.5% |
2000 | HK$8.62 | 4.72% |
1999 | HK$8.23 | 23.98% |
1998 | HK$6.64 | 40.16% |
1997 | HK$4.74 | 2.52% |
1996 | HK$4.62 |